Acadian Asset Management LLC Glycomimetics Inc Transaction History

Acadian Asset Management LLC

$28.7 Billion
Q1 2024

A detailed history of Acadian Asset Management LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 330,526 shares of GLYC stock, worth $109,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares

330,526

Previous 541,176 38.92%

Holding current value

$109,073

Previous $1.28 Million 22.27%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.55 - $3.49 $537,157 - $735,168	-210,650 Reduced 38.92%	330,526 $991,000
Q4 2023 Feb 13, 2024	SELL	$1.13 - $2.54 $342,248 - $769,302	-302,875 Reduced 35.88%	541,176 $1.28 Million
Q3 2023 Nov 13, 2023	SELL	$1.29 - $1.73 $394,230 - $528,696	-305,605 Reduced 26.58%	844,051 $1.27 Million
Q2 2023 Aug 07, 2023	SELL	$1.21 - $2.08 $304,916 - $524,153	-251,997 Reduced 17.98%	1,149,656 $2 Million
Q1 2023 May 11, 2023	SELL	$1.25 - $4.05 $676,756 - $2.19 Million	-541,405 Reduced 27.86%	1,401,653 $1.77 Million

Q4 2022 Feb 14, 2023	SELL	$0.67 - $3.03 $31,509 - $142,497	-47,029 Reduced 2.36%	1,943,058 $5.89 Million
Q1 2022 May 12, 2022	BUY	$1.0 - $1.58 $39,001 - $61,621	39,001 Added 2.0%	1,990,087 $2.27 Million
Q4 2021 Feb 10, 2022	BUY	$1.44 - $2.14 $93,598 - $139,097	64,999 Added 3.45%	1,951,086 $2.81 Million
Q3 2021 Nov 12, 2021	SELL	$1.8 - $2.39 $118,089 - $156,795	-65,605 Reduced 3.36%	1,886,087 $4.13 Million
Q2 2021 Aug 11, 2021	BUY	$2.16 - $3.18 $661,817 - $974,342	306,397 Added 18.62%	1,951,692 $4.53 Million
Q1 2021 May 11, 2021	BUY	$2.89 - $4.22 $2.41 Million - $3.53 Million	835,611 Added 103.2%	1,645,295 $4.95 Million
Q4 2020 Feb 11, 2021	BUY	$2.69 - $4.24 $1.02 Million - $1.61 Million	378,647 Added 87.85%	809,684 $3.04 Million
Q3 2020 Nov 09, 2020	BUY	$3.07 - $5.0 $507,044 - $825,805	165,161 Added 62.12%	431,037 $1.32 Million
Q2 2020 Aug 12, 2020	BUY	$2.06 - $3.76 $540,739 - $986,981	262,495 Added 7763.83%	265,876 $1 Million
Q4 2019 Feb 06, 2020	SELL	$4.03 - $6.5 $52,317 - $84,383	-12,982 Reduced 79.34%	3,381 $18,000
Q3 2019 Nov 07, 2019	BUY	$2.8 - $12.85 $45,816 - $210,264	16,363 New	16,363 $71,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

36.8M

Call Options Held

969K

Put Options Held

636K

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $17.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Glycomimetics Inc Transaction History